Generic Drug Labeling Updates The Target Of FDA Proposal
In a bid to improve the safety of generic drugs, the Food and Drug Administration has proposed a new rule that would allow the makers of such medications to be privy to the same regulations as name brand products. In doing, consumers and doctors alike could potentially gain access to pertinent information more quickly than… read more
Guilty Plea From Janssen In Wake Of Misbranding Accusations
Accusations about the introduction of a misbranded drug have led to a guilty plea by Janssen Pharmaceuticals, a branch of Johnson & Johnson. The company will have to pay a $400 criminal penalty and a $1.25 billion civil settlement in relation to events surrounding a drug called Risperdal. That drug was approved ten years ago… read more
Human and Pet Medications Are Not Interchangeable
One of the biggest challenges for pet owners is figuring both when an animal should be provided with some type of pain medication and what type of drug is acceptable for them. Rather than simply providing pets with the same pain medication than an owner would themselves take, citizens must realize that not all medications… read more
Potiga Label Outlining Vision Dangers Receives FDA Approval
A drug meant to treat partial-onset seizures in adults has received an updated boxed warning that outlines a recently uncovered hazard potentially posed to patients. The Food and Drug Administration lent its approval to the new label, which was deemed necessary in order to inform consumers of the potential for certain eye problems in persons… read more
FDA Striving To Bring Medicine Into An Era Of Personalization
When it comes to medical treatments, using a one-size-fits-all approach can be dangerous. Every individual is unique, and a treatment option that works for one person may end up killing or seriously injuring another. To make sure that everyone is receiving the medical care that they deserve, the Food and Drug Administration is investing heavily… read more
FDA Proposes New Classification For Hydrocodone
Hydrocodone, a drug that’s readily available in such medications as Vicodin, is a Schedule III substance that is widely prescribed throughout the country. This is seen by some as being problematic given the item’s highly addictive nature, and to combat the threat, the Food and Drug Administration has announced new recommendations focused on curbing the… read more
Sibutramine Presence Leads to Warning About Be Inspired Supplement
The presence of undeclared ingredients has led the Food and Drug Administration to warn persons against consuming a dietary supplement known as Be Inspired. Testing has revealed that the product, which was available online, is made up of Phenolphthalien and Sibutramine. The former is a laxative ingredient that the FDA years ago determined neither works… read more
Chemotherapy Drug Under FDA Investigation Following Adversity Reports
A chemotherapy medication provided to adult patients suffering from leukemia is under investigation by the Food and Drug Administration following an increase in the number of adverse event reports filed in association with the product. The drug is called Iclusig and the FDA is concerned about reported incidents in which a patient’s blood vessels became… read more
Ondansetron, Metoclopramide Injections Recalled Over Particulate Risk
Ondansetron Injections and Metoclopramide Injections are being recalled from across the country because of the potential presence of glass particulates within the products. Two lots of the former and one of the latter are impacted by the recall, and they would have been sent to medical facilities and pharmacies around the country between this past… read more
House Bill Seeks Expansion To Regulation Of Compounding Pharmacies
If you were to look at how things are going in terms of lawmakers passing a budget today, you would probably come away with a negative view of politics. Still, there are some issues that are able to unite members of both parties, and one of those issues is apparently the regulation of compounding pharmacies…. read more
Tracking Down Reumofan Maker Proves Difficult
Some people who suffer from joint pain or arthritis may turn to a dietary supplement known as Reumofan as a means to treat their condition. But a recent investigation from USA Today reveals that even tracking down the company behind the supplement has proven to be a difficult task, and when combined with the fact… read more
FDA Asks Parents To Keep Fentanyl Patches Away From Kids
For people that suffer from chronic pain, sometimes potent medications are seemingly the only way that they can find relief. When used properly and under the guidance of a qualified medical professional, these items should be safe for the user. But where things get tricky is when people not provided the prescription are able to… read more
